Citigroup’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Citigroup’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17K	Buy	+5,482	New	+$22.7K	﹤0.01%	4875
2025 Q1	–	Sell	-28	Closed	-$899	–	5616
2024 Q4	$899	Hold	28	–	–	﹤0.01%	5602
2024 Q3	$1.11K	Hold	28	–	–	﹤0.01%	5443
2024 Q2	$1.43K	Hold	28	–	–	﹤0.01%	5358
2024 Q1	$1.23K	Hold	28	–	–	﹤0.01%	5423
2023 Q4	$1.22K	Hold	28	–	–	﹤0.01%	5457
2023 Q3	$1.47K	Hold	28	–	–	﹤0.01%	5031
2023 Q2	$1.7K	Hold	28	–	–	﹤0.01%	5306
2023 Q1	$1.27K	Hold	28	–	–	﹤0.01%	5139
2022 Q4	$3.39K	Hold	28	–	–	﹤0.01%	5115
2022 Q3	$4K	Hold	28	–	–	﹤0.01%	5284
2022 Q2	$5K	Hold	28	–	–	﹤0.01%	5598
2022 Q1	$7K	Hold	28	–	–	﹤0.01%	5675
2021 Q4	$7K	Hold	28	–	–	﹤0.01%	5619
2021 Q3	$9K	Hold	28	–	–	﹤0.01%	5489
2021 Q2	$13K	Hold	28	–	–	﹤0.01%	5527
2021 Q1	$14K	Buy	+28	New	+$12.2K	﹤0.01%	5432
2016 Q2	–	Hold	0	–	–	–	7093
2016 Q1	–	Hold	0	–	–	–	7471
2015 Q4	–	Sell	-1	Closed	-$16K	–	7573
2015 Q3	$16K	Buy	+1	New	+$6.71K	﹤0.01%	6169
2015 Q2	–	Hold	0	–	–	–	7530
2015 Q1	–	Hold	0	–	–	–	7030
2014 Q4	–	Hold	0	–	–	–	6845
2014 Q2	–	Hold	0	–	-$2K	–	7120
2014 Q1	–	Hold	0	–	–	–	6769

Other funds holding CANF

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Citigroup's CANF Position: Q1 2026 in Review

Citigroup opened a new position in Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026: 5,482 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #4875 among its holdings. This is a return to the name: Citigroup previously reported a position in CANF as recently as Q4 2024.

Citigroup first reported a position in CANF in Q3 2015 and has held it in 18 quarters since. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

Citigroup held 5,482 shares of Can-Fite BioPharma American Depositary Shares worth $17K as of Q1 2026.
Can-Fite BioPharma American Depositary Shares was a new Citigroup position in Q1 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4875 holding.
Citigroup first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2015 and has held it in 18 quarters since.
14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.